Effect of Repetitive Intra-Arterial Infusion of Bone Marrow Mononuclear Cells in Patients With No-Option Limb Ischemia

Martin Teraa(Maine Farmland Trust), Marianne C. Verhaar(Utrecht University), Ralf W. Sprengers(Amsterdam University Medical Centers), Ale Algra(University Medical Center Utrecht), Frans L. Moll(Metallco (Norway)), Roger E. G. Schutgens(University Medical Center Utrecht), Ineke Slaper‐Cortenbach(Maine Farmland Trust), Pieter A. Doevendans(Central Military Hospital), Yolanda van der Graaf(SUNY Downstate Health Sciences University), Ingeborg van der Tweel(Radboud University Nijmegen), Willem P.Th.M. Mali(Utrecht University)
Circulation
January 8, 2015
10.1161/circulationaha.114.012913
Cited by 181

Related Papers

Editor's Choice – Management of Descending Thoracic Aorta Diseases
|European Journal of Vascular and Endovascular Surgery|2017|1.2k
Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis
|The Lancet|2021|997
Worldwide Incidence of Aneurysmal Subarachnoid Hemorrhage According to Region, Time Period, Blood Pressure, and Smoking Prevalence in the Population
|JAMA Neurology|2019|896
Long-term outcomes after stenting versus endarterectomy for treatment of symptomatic carotid stenosis: the International Carotid Stenting Study (ICSS) randomised trial
|The Lancet|2014|544
Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study
|The Lancet Neurology|2009|428